Luciana Lontro Alves

Ms. Luciana Lontro Alves

Department of Histology and Embryology, Rio de Janeiro State University, Rio de Janeiro, Brazil
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Priscila Gomes PereiraPriscila Gomes Pereira
Priscila Gomes Pereira
Luciana Lontro AlvesLuciana Lontro Alves
Luciana Lontro Alves
BCBianca Ciambarella
Bianca Ciambarella
Kíssila RabeloKíssila Rabelo
Kíssila Rabelo
ANAna Lúcia R. Nascimento
Ana Lúcia R. Nascimento
JCJorge José Carvalho
Jorge José Carvalho
Obesity is an inflammatory disease associated with secondary diseases such as kidney disease, which can cause lipotoxicity, inflammation and loss of organ function. Polyunsaturated fatty acids act in the production of lipid mediators and have anti-inflammatory characteristics. In this work, the objective was to evaluate renal histopathology in obese mice and the effects of treatment with capybara oil (CO) (5000 mg/kg/day for 4 weeks). Parameters such as body mass, lipid profile, systolic blood pressure, urinary creatinine and protein excretion, structure and ultrastructure of the renal cortex, fibrosis, tissue inflammation and oxidative stress were analyzed. CO treatment in obese mice showed improvement in the lipid profile and reduction in systolic blood pressure levels, in addition to beneficial remodeling of the renal cortex. Our data demonstrated that CO decreased inflammation, oxidative stress and renal fibrosis, as evidenced by quantifying the expression of TNF-α, IL-10, CAT, SOD, α-SMA and TGF-β. Although treatment with CO did not show improvement in renal function, ultrastructural analysis showed that the treatment was effective in restoring podocytes and pedicels, with restructuring of the glomerular filtration barrier. These results demonstrate, for the first time, that treatment with CO is effective in reducing kidney damage, being considered a promising treatment for obesity.

10 October 2020 in International Journal of Hypertension
Verified
Journal Article
Open access
VMVeronica S. de Matos
Veronica S. de Matos
ANAna L. R. Do Nascimento
Ana L. R. Do Nascimento
PPPriscila G. Pereira
Priscila G. Pereira
Kíssila RabeloKíssila Rabelo
Kíssila Rabelo
CACherley B. V. Andrade
Cherley B. V. Andrade
JCJorge José Carvalho
Jorge José Carvalho
Hypertension is a disease classified as primary or secondary, manifested not only by elevation of blood pressure but also involved in structural and functional changes of target organs. Renal artery stenosis is a leading factor of secondary hypertension, and its progress is associated with overactivation of the renin-angiotensin-aldosterone system (RAAS). Aliskiren is a renin inhibiting drug that suppresses RAAS and culminates in decreased renin release, plasma angiotensin II concentration, and inhibition of aldosterone secretion. In this sense, the aim of the present study was to analyze the structural and ultrastructural morphophysiology of the adrenal glomerular zone, after treatment with aliskiren in Wistar rats with 2K1C hypertension. Parameters as structure and ultrastructure of the adrenal glomerular zone, cellular apoptosis, nuclear cell proliferation, and AT1 receptor expression were analyzed by immunostaining and electron microscopy. Our results showed that the hypertensive animals treated with aliskiren presented a reestablishment of AT1 receptor expression and decrease in apoptosis and autophagy. In addition, treatment with aliskiren improves the cell aspects in the adrenal glomerular zone, evidenced by ultrastructural analysis through preserved nuclei and well-developed mitochondria. Therefore, our evidence suggests that aliskiren has a beneficial effect on the adrenal glomerular zone remodeling in animals with renovascular hypertension.

1 January 2024 in Journal of Obesity
Verified
Journal Article
Open access
PDF file
Luciana Lontro AlvesLuciana Lontro Alves
Luciana Lontro Alves
Priscila Gomes PereiraPriscila Gomes Pereira
Priscila Gomes Pereira
BCBianca Ciambarella
Bianca Ciambarella
MCMiguel Porto Campos
Miguel Porto Campos
Kíssila RabeloKíssila Rabelo
Kíssila Rabelo
JCJorge José Carvalho
Jorge José Carvalho
Obesity is a complex chronic disease characterized by excess body fat (adipose) that is harmful to health and has been a major global health problem. It may be associated with several diseases, such as nonalcoholic fatty liver disease (NAFLD). Polyunsaturated fatty acids (PUFA) are lipid mediators that have anti‐inflammatory characteristics and can be found in animals and plants, with capybara oil (CO) being a promising source. So, we intend to evaluate the hepatic pathophysiological alterations in C57Bl/6 mice with NAFLD, caused by obesity, and the possible beneficial effects of OC in the treatment of this disease. Eighteen 3‐month‐old male C57Bl/6 mice received a control or high‐fat diet for 18 weeks. From the 15th to the 18th week, the animals received treatment—through orogastric gavage—with placebo or free capybara oil (5 g/kg). Parameters inherent to body mass, glucose tolerance, evaluation of liver enzymes, percentage of hepatic steatosis, oxidative stress, the process of cell death with the apoptotic biomarkers (Bax, Bcl2, and Cytochrome C), and the ultrastructure of hepatocytes were analyzed. Even though the treatment with CO was not able to disassemble the effects on the physiological parameters, it proved to be beneficial in reversing the morphological and ultrastructural damage present in the hepatocytes. Thus, demonstrating that CO has beneficial effects in reducing steatosis and the apoptotic pathway, it is a promising treatment for NAFLD.

25 February 2022 in Brazilian Journal of Health and Biomedical Sciences
Verified
Journal Article
Open access
Luciana Lontro AlvesLuciana Lontro Alves
Luciana Lontro Alves
LTLuiza Torres-Nunes
Luiza Torres-Nunes
MLMarcella De Lucena-Machado
Marcella De Lucena-Machado
YAYanca Maiara A. De Azevedo
Yanca Maiara A. De Azevedo
DSDanúbia Da C. De Sá-Caputo
Danúbia Da C. De Sá-Caputo
MBMario Bernardo-Filho
Mario Bernardo-Filho
Introduction: Vitamin D is involved in several human metabolismpathways, both in classic pathway, which involvesthe calcium and phosphorus metabolism, and in non-classicpathways, which are related to several types of diseases, includingdiseases related to muscles; kidneys; cardiovascular system;immune system; some types of cancer; diabetes; and pregnancy.Objectives: As cancer is one of the main health problems inthe world and knowing that it is one of the non-classic effectsrelated to vitamin D, the current narrative review aimed toverify the relevance of vitamin D has on the types of cancer.Methods: The bibliographic research was performed in databasesPubmed, Scopus and PEDro on June 16, 2020, using thekeywords “vitamin D”, “cancer” and “non-classic”. Only articlessince the year 2000 were included. Thirty-one articles wereanalyzed relating vitamin D to colon/rectum cancer, breastcancer, prostate cancer, lung cancer, ovarian cancer, melanomaand other types of skin cancer, and gastric cancer. Results: Allstudies have shown a relationship between vitamin D and theincidence of cancer in the human body, however, there arepeculiarities regarding the concentration levels in each organ.Even with conflicting results, in general, vitamin D has shownto be promise in the prevention of several types of cancer.

27 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CVCarla Bianca Victorio
Carla Bianca Victorio
ATAndrew Teo
Andrew Teo
SGShantanu Gupta
Shantanu Gupta
AGArun Ganasarajah
Arun Ganasarajah
JOJoanne L Ong
Joanne L Ong
ACAnn-Marie Chacko
Ann-Marie Chacko
Severe dengue can damage the liver through unestablished mechanisms. We investigated the role of myeloperoxidase (MPO), a neutrophil enzyme, in dengue through patients, fatal liver samples, and mouse infection models. Observations from two independent clinical cohorts revealed elevated plasma MPO levels in dengue and, in one cohort, MPO was further linked to liver injury markers during the critical phase of disease, whereas livers from dengue fatal cases revealed MPO build-up in the vicinity of CD177+ activated neutrophils. In mice, dengue led to MPO overexpression, oxidative damage, and broad activation of innate and systemic inflammatory pathways in livers. Blocking MPO activity alleviated these and improved survival in one model and delayed disease progression without preventing death in another. These findings establish MPO as a functional mediator of severe dengue-associated liver injury and inflammation, which warrants further preclinical investigation into its hepatic pathogenic mechanism and its validity as target for therapeutic intervention.

5 October 2026 in Cell Biochemistry and Function
Verified
Journal Article
Open access
PDF file
PPPriscila G. Pereira
Priscila G. Pereira
Luciana Lontro AlvesLuciana Lontro Alves
Luciana Lontro Alves
BCBianca Ciambarella
Bianca Ciambarella
SFStela R. Ferrarini
Stela R. Ferrarini
ANAna Lúcia R. Nascimento
Ana Lúcia R. Nascimento
JCJorge José Carvalho
Jorge José Carvalho
Obesity is a multifactorial disorder associated with systemic metabolic alterations and increased risk of renal injury, largely driven by chronic inflammation and oxidative stress. Bioactive lipids, particularly polyunsaturated fatty acids, have been shown to exert protective effects; however, their instability and susceptibility to oxidation may limit their therapeutic potential. In this study, we investigated the effects of a capybara oil‐based nanoemulsion (NE‐CO) on renal dysfunction in a mouse model of obesity. Male mice were subjected to diet‐induced obesity and treated with NE‐CO (100 mg/kg/day) for 4 weeks. Metabolic parameters, systolic blood pressure, urinary biomarkers, and renal morphology were evaluated. In addition, markers of inflammation, oxidative stress, and fibrosis were assessed to elucidate potential mechanisms. NE‐CO treatment significantly reduced body mass and systolic blood pressure, while improving renal function, as evidenced by decreased proteinuria and normalization of urinary creatinine levels. Histological and ultrastructural analyzes revealed marked improvements in renal cortical organization. These effects were accompanied by reduced expression of pro‐inflammatory markers, enhanced antioxidant defenses, and attenuation of fibrotic remodeling. Collectively, these findings demonstrate that NE‐CO mitigates obesity‐induced renal injury, at least in part, through modulation of inflammatory, oxidative, and fibrotic pathways. This study highlights the therapeutic potential of bioactive lipid delivery systems in the context of metabolic and renal disorders.